After a brief hiatus, Pharmalot has found a new home with The Wall Street Journal as part of its ongoing commitment to provide must-read coverage of the pharmaceutical industry.. Readers can expect to see a rich menu of blog posts about the fast-moving and complicated world that develops and markets medicines. The long-standing mission will be familiar – to offer a breezy mix of news and analysis of the pharmaceutical industry, as well as an opportunity to discuss events and issues.